Danimer Scientific, Inc. Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020
Revenues
Products
Services
Total revenues
Costs and expenses:
Cost of revenue
Selling, general and administrative
Research and development
Loss on sale of assets
Legal settlement
Impairment of long-lived assets
Total costs and expenses
Loss from operations
Nonoperating income (expense):
Interest expense
Gain on remeasurement of private warrants
Interest, net
Gain on forgiveness of debt
Gain on loan extinguishment
Interest income
Other, net
Loss before income taxes
Total nonoperating income (expense):
Loss before income taxes

Income taxes
Net loss
Basic and diluted net loss per share (in Dollars per share)
Weighted average number of common shares used to compute basic and diluted net loss per common share (in Shares)
Basic net loss per share
Diluted net loss per share

Comments